Therese M. Mulvey
- Oncology top 5%
- Cancer Treatment and Pharmacology 4
- Cancer survivorship and care 4
- Economics and Econometrics top 2%
- Economic and Financial Impacts of Cancer 11
- Health Systems, Economic Evaluations, Quality of Life 4
- Cancer Research top 10%
- Family Practice top 10%
-
- Advanced Breast Cancer Therapies 7
-
- BRCA gene mutations in cancer 4
-
- Advances in Oncology and Radiotherapy 4
-
- Patient Safety and Medication Errors 3
- Co-authors
- Thomas J. SmithLowell E. SchnipperDana S. WollinsPatricia A. GanzDerek RaghavanDouglas W. BlayneyDeborah SchragNeal J. Meropol
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (4 papers)Annals of Oncology (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Therese M. Mulvey
39 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 697
- Economics and Econometrics 539
- Public Health, Environmental and Occupational Health 356
- Cancer Research 177
- Family Practice 22
Countries citing papers authored by Therese M. Mulvey
This map shows the geographic impact of Therese M. Mulvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therese M. Mulvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therese M. Mulvey more than expected).
Fields of papers citing papers by Therese M. Mulvey
This network shows the impact of papers produced by Therese M. Mulvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Therese M. Mulvey. The network helps show where Therese M. Mulvey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Therese M. Mulvey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 27 | |
| 6 | 2021 | 92 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 3 | |
| 12 | 2019 | 26 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 11 | |
| 15 | 2014 | 2 | |
| 16 | 2012 | 0 | |
| 17 | American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncologybreakdown → | 2012 | 458 |
| 18 | 2008 | 1 | |
| 19 | 2006 | 0 | |
| 20 | 2004 | 28 |
About Therese M. Mulvey
Therese M. Mulvey is a scholar working on Oncology, Economics and Econometrics and Health Information Management, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (11 papers), Advanced Breast Cancer Therapies (7 papers), BRCA gene mutations in cancer (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer survivorship and care (4 papers), Advances in Oncology and Radiotherapy (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Patient Safety and Medication Errors (3 papers). The work is most often cited by research in Oncology (697 citations), Economics and Econometrics (539 citations) and Public Health, Environmental and Occupational Health (356 citations). Therese M. Mulvey has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Thomas J. Smith, Lowell E. Schnipper, Dana S. Wollins, Patricia A. Ganz, Derek Raghavan, Douglas W. Blayney, Deborah Schrag, Neal J. Meropol, Peter A. Ubel and Diane Blum. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.